Radiofrequency ablation of genicular nerves prior to total knee replacement has no effect on postoperative pain outcomes

A prospective randomized sham-controlled trial with 6-month follow-up

David R Walega*, Zachary McCormick, David W Manning, Michael J Avram

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and objectives Refractory chronic knee pain from osteoarthritis (OA) is commonly treated with total knee arthroplasty (TKA). TKA can be associated with severe postoperative pain and persistent postsurgical knee pain. Poorly controlled postoperative pain can negatively effect functional outcomes following TKA, and effective opioid-sparing analgesia is key to the ideal recovery. Genicular nerve radiofrequency ablation (GN-RFA) has been shown in several trials to be clinically effective in patients with severe refractory knee pain from OA. We aimed to assess if preoperative GN-RFA would improve postoperative pain outcomes following TKA. Methods This was a sham-control prospective clinical trial in which blinded participants were randomized to image-guided GN-RFA or a simulated sham procedure 2-6 weeks prior to elective TKA. Outcomes were assessed at 48 hours and 1, 3 and 6 months following TKA. Results Seventy participants enrolled in this study. As compared with sham controls, GN-RFA had no treatment effect on postoperative opioid consumption, pain or functional measures at any time point. Conclusions Cooled RFA of the superior lateral, superior medial and inferomedial genicular nerves, when performed 2-6 weeks prior to elective TKA as part of a multimodal postoperative pain management regime, had no measurable effect on postoperative opioid use, analgesia use or function in the 48 hours following surgery. In addition, we found no longer term effect on outcome measures 1, 3 and 6 months after TKA. Trial registration number NCT02746874.

Original languageEnglish (US)
Pages (from-to)646-651
Number of pages6
JournalRegional anesthesia and pain medicine
Volume44
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Knee Replacement Arthroplasties
Postoperative Pain
Knee
Randomized Controlled Trials
Opioid Analgesics
Intractable Pain
Knee Osteoarthritis
Analgesia
Pain
Pain Management
Chronic Pain
Outcome Assessment (Health Care)
Clinical Trials

Keywords

  • genicular nerve ablation
  • knee osteoarthritis
  • knee pain
  • radiofrequency ablation

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

@article{e73dce164ca145d1bb1a4628bfa45b01,
title = "Radiofrequency ablation of genicular nerves prior to total knee replacement has no effect on postoperative pain outcomes: A prospective randomized sham-controlled trial with 6-month follow-up",
abstract = "Background and objectives Refractory chronic knee pain from osteoarthritis (OA) is commonly treated with total knee arthroplasty (TKA). TKA can be associated with severe postoperative pain and persistent postsurgical knee pain. Poorly controlled postoperative pain can negatively effect functional outcomes following TKA, and effective opioid-sparing analgesia is key to the ideal recovery. Genicular nerve radiofrequency ablation (GN-RFA) has been shown in several trials to be clinically effective in patients with severe refractory knee pain from OA. We aimed to assess if preoperative GN-RFA would improve postoperative pain outcomes following TKA. Methods This was a sham-control prospective clinical trial in which blinded participants were randomized to image-guided GN-RFA or a simulated sham procedure 2-6 weeks prior to elective TKA. Outcomes were assessed at 48 hours and 1, 3 and 6 months following TKA. Results Seventy participants enrolled in this study. As compared with sham controls, GN-RFA had no treatment effect on postoperative opioid consumption, pain or functional measures at any time point. Conclusions Cooled RFA of the superior lateral, superior medial and inferomedial genicular nerves, when performed 2-6 weeks prior to elective TKA as part of a multimodal postoperative pain management regime, had no measurable effect on postoperative opioid use, analgesia use or function in the 48 hours following surgery. In addition, we found no longer term effect on outcome measures 1, 3 and 6 months after TKA. Trial registration number NCT02746874.",
keywords = "genicular nerve ablation, knee osteoarthritis, knee pain, radiofrequency ablation",
author = "Walega, {David R} and Zachary McCormick and Manning, {David W} and Avram, {Michael J}",
year = "2019",
month = "6",
day = "1",
doi = "10.1136/rapm-2018-100094",
language = "English (US)",
volume = "44",
pages = "646--651",
journal = "Regional Anesthesia and Pain Medicine",
issn = "1098-7339",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Radiofrequency ablation of genicular nerves prior to total knee replacement has no effect on postoperative pain outcomes

T2 - A prospective randomized sham-controlled trial with 6-month follow-up

AU - Walega, David R

AU - McCormick, Zachary

AU - Manning, David W

AU - Avram, Michael J

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Background and objectives Refractory chronic knee pain from osteoarthritis (OA) is commonly treated with total knee arthroplasty (TKA). TKA can be associated with severe postoperative pain and persistent postsurgical knee pain. Poorly controlled postoperative pain can negatively effect functional outcomes following TKA, and effective opioid-sparing analgesia is key to the ideal recovery. Genicular nerve radiofrequency ablation (GN-RFA) has been shown in several trials to be clinically effective in patients with severe refractory knee pain from OA. We aimed to assess if preoperative GN-RFA would improve postoperative pain outcomes following TKA. Methods This was a sham-control prospective clinical trial in which blinded participants were randomized to image-guided GN-RFA or a simulated sham procedure 2-6 weeks prior to elective TKA. Outcomes were assessed at 48 hours and 1, 3 and 6 months following TKA. Results Seventy participants enrolled in this study. As compared with sham controls, GN-RFA had no treatment effect on postoperative opioid consumption, pain or functional measures at any time point. Conclusions Cooled RFA of the superior lateral, superior medial and inferomedial genicular nerves, when performed 2-6 weeks prior to elective TKA as part of a multimodal postoperative pain management regime, had no measurable effect on postoperative opioid use, analgesia use or function in the 48 hours following surgery. In addition, we found no longer term effect on outcome measures 1, 3 and 6 months after TKA. Trial registration number NCT02746874.

AB - Background and objectives Refractory chronic knee pain from osteoarthritis (OA) is commonly treated with total knee arthroplasty (TKA). TKA can be associated with severe postoperative pain and persistent postsurgical knee pain. Poorly controlled postoperative pain can negatively effect functional outcomes following TKA, and effective opioid-sparing analgesia is key to the ideal recovery. Genicular nerve radiofrequency ablation (GN-RFA) has been shown in several trials to be clinically effective in patients with severe refractory knee pain from OA. We aimed to assess if preoperative GN-RFA would improve postoperative pain outcomes following TKA. Methods This was a sham-control prospective clinical trial in which blinded participants were randomized to image-guided GN-RFA or a simulated sham procedure 2-6 weeks prior to elective TKA. Outcomes were assessed at 48 hours and 1, 3 and 6 months following TKA. Results Seventy participants enrolled in this study. As compared with sham controls, GN-RFA had no treatment effect on postoperative opioid consumption, pain or functional measures at any time point. Conclusions Cooled RFA of the superior lateral, superior medial and inferomedial genicular nerves, when performed 2-6 weeks prior to elective TKA as part of a multimodal postoperative pain management regime, had no measurable effect on postoperative opioid use, analgesia use or function in the 48 hours following surgery. In addition, we found no longer term effect on outcome measures 1, 3 and 6 months after TKA. Trial registration number NCT02746874.

KW - genicular nerve ablation

KW - knee osteoarthritis

KW - knee pain

KW - radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=85067952880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067952880&partnerID=8YFLogxK

U2 - 10.1136/rapm-2018-100094

DO - 10.1136/rapm-2018-100094

M3 - Article

VL - 44

SP - 646

EP - 651

JO - Regional Anesthesia and Pain Medicine

JF - Regional Anesthesia and Pain Medicine

SN - 1098-7339

IS - 6

ER -